Drabczyk R, Grzeszczak W, Trelewicz P
Oddziału Nefrologicznego i Oddziału Sztucznej Nerki Specjalistycznego Szpitala Miejskiego Stalownik, Bielsku-Białej.
Pol Arch Med Wewn. 1992 Dec;88(6):368-80.
Many disturbances is functioning of pituitary-thyroid axis in patients with advanced chronic renal failure are well documented. The present paper aimed to assess the influence of duration of haemodialysis treatment on the basal and after TRH stimulation TT3, fT3 and rT3 serum concentration in uremic patients. 17 nondialyzed uraemic patients, 15 dialysed up to 50 months, 11 dialysed for 51-100 months, 11 dialysed for more than 100 months and 14 control subjects were examined. In all subjects TT3, fT3, and rT3 levels were assessed before and after TRH administration (400 micrograms i.v.).
Duration of haemodialysis treatment is a important factor influencing serum TT3, fT3 and rT3 concentration. This effect is observed in partial normalisation of: a) basal TT3 and fT3, b) reactivity of TT3 and fT3 after THR administration.
晚期慢性肾衰竭患者垂体 - 甲状腺轴功能存在多种紊乱已得到充分证实。本文旨在评估血液透析治疗时长对尿毒症患者基础状态及促甲状腺激素释放激素(TRH)刺激后血清总三碘甲状腺原氨酸(TT3)、游离三碘甲状腺原氨酸(fT3)和反三碘甲状腺原氨酸(rT3)浓度的影响。研究了17例未透析的尿毒症患者、15例透析时长达50个月的患者、11例透析时长为51 - 100个月的患者、11例透析时长超过100个月的患者以及14例对照者。对所有受试者在静脉注射400微克TRH前后评估TT3、fT3和rT3水平。
血液透析治疗时长是影响血清TT3、fT3和rT3浓度的重要因素。这种影响体现在以下方面的部分正常化:a)基础TT3和fT3;b)TRH给药后TT3和fT3的反应性。